Deferred Tax Assets, Net of Valuation Allowance of Propanc Biopharma, Inc. from 30 Jun 2011 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Propanc Biopharma, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 30 Jun 2011 to 30 Jun 2025.
  • Propanc Biopharma, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 30 Jun 2025 was $23,846,119, a 108% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $23,846,119 +$12,383,827 +108% 30 Jun 2025 10-K 29 Sep 2025 2025 FY
Q2 2024 $11,462,292 +$306,682 +2.7% 30 Jun 2024 10-K 29 Sep 2025 2025 FY
Q2 2023 $11,155,610 +$861,178 +8.4% 30 Jun 2023 10-K 30 Sep 2024 2024 FY
Q2 2022 $10,294,432 +$339,334 +3.4% 30 Jun 2022 10-K 28 Sep 2023 2023 FY
Q2 2021 $9,955,098 +$1,146,001 +13% 30 Jun 2021 10-K 28 Sep 2022 2022 FY
Q2 2020 $8,809,097 +$1,137,716 +15% 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q2 2019 $7,671,381 30 Jun 2019 10-K 01 Oct 2020 2020 FY
Q2 2013 $18,512* +$1,768 30 Jun 2013 10-K 15 Oct 2013 2013 FY
Q2 2012 $16,744* -$10,815,256 30 Jun 2012 10-K 15 Oct 2013 2013 FY
Q2 2011 $10,832,000 30 Jun 2011 10-K 15 Oct 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.